March 17, 2026

Introducing our New Members – Q1 2026

Introducing our New Members – Q1 2026

We are pleased to introduce these new members and highlight the diverse capabilities they bring to our cluster! Looking forward to your active participation!


Bioneer A/S
https://bioneer.dk/
Bioneer is an R&D-driven CRO and CDMO and a Danish government-approved RTO with 40 years of experience. The company supports biotech and pharma partners in drug discovery, early development, and manufacturing, delivering customized solutions for early drug candidates, recombinant proteins, and key preclinical insights.
5-HT Chemistry & Health
https://www.5-ht.com/
5-HT Chemistry & Health is a global innovation ecosystem based in Ludwigshafen, connecting the fields of chemistry and health. It brings together corporates, startups, investors, and academic partners to foster innovation, digitalization, and collaboration. 5-HT enables networking, cooperation, and co-development, supporting innovation journeys, strategies, and a strong cross-sector community. Its mission is to help shape the digital and sustainable future of chemistry and health through technology-driven collaboration.
5-HT is part of the German Digital Hub Initiative (de:hub) and the Baden-Württemberg Digihub network. Its shareholders include BASF, SAP, the Rhine-Neckar Metropolitan Region, and the startup centers of Mannheim, Heidelberg, and Ludwigshafen.
HEMEX AG
https://hemex.ch/
Hemex is a European Contract Research Organization (CRO) supporting pharmaceutical, biotech, and medtech SMEs with end-to-end pre-clinical & clinical development solutions. Headquartered in the Basel region, with offices in Germany, Benelux, and across three continents, Hemex specializes in multinational clinical trials. Services include clinical operations, regulatory support, quality assurance, BA/BE, PK, and Phase I studies, rapid patient recruitment, and imaging core lab services.
ImmunoEdge
https://www.linkedin.com/company/immunoedge/about/
ImmunoEdge is a Heidelberg-based biotech startup developing a high-sensitivity, low-loss technology to uncover clinically relevant tumor peptides from minimally invasive biopsies. By enabling actionable target discovery and longitudinal monitoring throughout treatment, ImmunoEdge supports next generation immunotherapies.
KONEXIO BIOTECH, S.L.
https://konexiobiotech.com/en/about-us/
Konexio Biotech provides technical consulting across the full development pathway of biotechnological and pharmaceutical products. With a multidisciplinary team of experts in biomedical sciences, pharmacy, and engineering, the company delivers strategic technical and regulatory solutions to help innovative products successfully reach the healthcare market and patients.
Lonza AG
https://www.lonza.com/
Lonza is one of the world’s largest healthcare manufacturing organizations, employing around 20,000 people across five continents. The company supports pharmaceutical and biotech partners with advanced technologies, scientific expertise, and world-class manufacturing to bring innovative therapies to market. In 2025, Lonza generated sales of CHF 6.5 billion with a CORE EBITDA of CHF 2.1 billion.
PICO BioScience GmbH (Formerly: Actome GmbH)
https://www.pico-bioscience.eu
PICO BioScience accelerates life science research and drug discovery through its proprietary Protein Interaction Coupling (PICO) technology. Their kits deliver high-throughput, absolute quantification of extracellular vesicles (EVs), proteins, and post-translational modifications with unmatched specificity.
They empower the global scientific community with: Innovative PICO Kits: High-performance tools for in-house research.
Tailored PICO Services: Expert assay development and proteomic studies.
SERVA Electrophoresis GmbH
https://www.serva.de/enDE/index.html
SERVA has over 60 years of experience supplying high-quality reagents to scientists worldwide. The company combines expertise in manufacturing, development, and distribution with strong customer service and a commitment to innovation in the life sciences. Guided by technical excellence and total quality management, SERVA upholds the highest standards in product quality, workplace safety, environmental responsibility, and is certified to ISO 9001:2015.
Zentralinstitut für Seelische Gesundheit (ZI)
https://www.zi-mannheim.de/index.html
The Central Institute of Mental Health is a leading European center for research and treatment in psychiatry, psychotherapy, child and adolescent psychiatry, psychosomatic medicine, and addiction medicine. Its four clinics provide advanced psychiatric care for Mannheim’s population. In close collaboration with Heidelberg University and as part of national research alliances, the institute combines cutting-edge research with clinical excellence and employs over 1,400 staff.

Our latest News

discover more
GeneNovate® 2026: Heidelberger Forschende stärken unternehmerisches Denken für die nächste Generation von Gen- und Zelltherapien

GeneNovate® 2026: Heidelberger Forschende stärken unternehmerisches Denken für die nächste Generation von Gen- und Zelltherapien

Heidelberg, Juni 2026 – Mit dem Final Event von GeneNovate® am 25. Juni in der Münchner Residenz endet die dritte Runde des bundesweiten Entrepreneurship-Programms der Nationalen Strategie für gen- und zellbasierte Therapien (Nationale Strategie GCT). Im Rahmen der Abschlussveranstaltung präsentierten Wissenschaftlerinnen und Wissenschaftler aus ganz Deutschland ihre innovativen Geschäftsideen mit Potenzial für zukünftige Gesundheitslösungen und […]

Post-COVID Syndrome: Study Finds Hemodialysis Offers No Benefit to Patients

Post-COVID Syndrome: Study Finds Hemodialysis Offers No Benefit to Patients

A study recently published in *The Lancet Regional Health – Europe* calls into question the benefits of immunoadsorption—a specialized form of blood purification—for post-COVID syndrome. While the autoantibodies, which are thought to be a possible cause of the condition, can be removed from the blood, this does not improve the symptoms of those affected. The […]

Universität Heidelberg: Humboldt Professorship for Leading International Researcher

Universität Heidelberg: Humboldt Professorship for Leading International Researcher

Highly endowed research prize goes to Harvard scientist Mathias Lichterfeld on the proposal of Ruperto Carola In order to further strengthen Heidelberg University as an internationally recognized location of infection research, Prof. Dr Mathias Lichterfeld has been selected for an Alexander von Humboldt Professorship endowed with 7.8 million euros. Leading international academics are granted this […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp